Cowealth Medical China Co.,Ltd. (SHA:603122)
9.79
+0.89 (10.00%)
Last updated: Oct 31, 2025, 11:29 AM CST
Cowealth Medical China Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -11.37 | 27.57 | 47.19 | 82.72 | 80.23 | 72.55 | Upgrade |
Depreciation & Amortization | 8.1 | 8.86 | 10.65 | 11.19 | 14.14 | 15.69 | Upgrade |
Other Amortization | 10.82 | 10.07 | 7.11 | 11.93 | 7.77 | 2.15 | Upgrade |
Loss (Gain) From Sale of Assets | -0.44 | -0.44 | -0.1 | -0.2 | 0 | 0.07 | Upgrade |
Asset Writedown & Restructuring Costs | 0.02 | 0.02 | 0.02 | 0.36 | 1.06 | 0.41 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | -0.07 | -0.64 | - | -1.46 | Upgrade |
Provision & Write-off of Bad Debts | -10.24 | -10.24 | -2.88 | 2.47 | 3 | 14.74 | Upgrade |
Other Operating Activities | 155.22 | 8.67 | 6.99 | 4.8 | -2.81 | 2.72 | Upgrade |
Change in Accounts Receivable | 46.65 | 46.65 | 1.65 | -234.74 | -70.83 | -29.22 | Upgrade |
Change in Inventory | -12.06 | -12.06 | 7.44 | -27.21 | -39.57 | -35.2 | Upgrade |
Change in Accounts Payable | 49.35 | 49.35 | -64.21 | 121.67 | 10.33 | 31.17 | Upgrade |
Change in Other Net Operating Assets | - | - | - | - | 0.32 | 0.99 | Upgrade |
Operating Cash Flow | 240.36 | 132.75 | 11.28 | -30.37 | 7.01 | 74.15 | Upgrade |
Operating Cash Flow Growth | 286.33% | 1076.77% | - | - | -90.55% | - | Upgrade |
Capital Expenditures | -18.28 | -31.82 | -67.96 | -25.94 | -22.12 | -8.11 | Upgrade |
Sale of Property, Plant & Equipment | 0.75 | 0.8 | 0.12 | 0.47 | 0.03 | 0 | Upgrade |
Cash Acquisitions | - | - | - | - | - | -81.41 | Upgrade |
Investment in Securities | -5.56 | - | 11.18 | -5.36 | - | 222.99 | Upgrade |
Other Investing Activities | -80.68 | 2.13 | 5.01 | 4.92 | 4.67 | 7.27 | Upgrade |
Investing Cash Flow | -103.76 | -28.9 | -51.65 | -25.91 | -17.43 | 140.74 | Upgrade |
Long-Term Debt Issued | - | 529.67 | 715.34 | 309.72 | 429.21 | 254.53 | Upgrade |
Long-Term Debt Repaid | - | -548.02 | -726.43 | -367.14 | -431.08 | -223.36 | Upgrade |
Net Debt Issued (Repaid) | -84.36 | -18.36 | -11.09 | -57.42 | -1.86 | 31.17 | Upgrade |
Issuance of Common Stock | - | - | - | 380.6 | - | - | Upgrade |
Common Dividends Paid | -54.35 | -26.95 | -65.25 | -74.54 | -79.65 | -46.2 | Upgrade |
Other Financing Activities | -1.56 | -0.17 | -2.54 | -22.92 | -8.09 | -4.22 | Upgrade |
Financing Cash Flow | -140.27 | -45.48 | -78.87 | 225.73 | -89.61 | -19.25 | Upgrade |
Foreign Exchange Rate Adjustments | 0.97 | 0.25 | -0.39 | 1.17 | -2.44 | -1.91 | Upgrade |
Net Cash Flow | -2.7 | 58.63 | -119.63 | 170.62 | -102.46 | 193.74 | Upgrade |
Free Cash Flow | 222.08 | 100.93 | -56.68 | -56.31 | -15.11 | 66.05 | Upgrade |
Free Cash Flow Margin | 28.58% | 10.75% | -5.19% | -4.40% | -1.27% | 6.07% | Upgrade |
Free Cash Flow Per Share | 0.53 | 0.26 | -0.14 | -0.15 | -0.05 | 0.22 | Upgrade |
Cash Income Tax Paid | 22.4 | 37.13 | 55.71 | 62.36 | 66.16 | 56.83 | Upgrade |
Levered Free Cash Flow | 175.53 | 82.13 | -73.65 | -87.22 | -113.8 | 62.81 | Upgrade |
Unlevered Free Cash Flow | 175.78 | 84.21 | -69.98 | -84.57 | -110.95 | 64.92 | Upgrade |
Change in Working Capital | 88.24 | 88.24 | -57.63 | -143 | -96.38 | -32.72 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.